A new report by IQVIA reveals that Europe has lost its dominance in pharmaceutical clinical trials over the past decade, with its share dropping from 22% in 2013 to 12% in 2023, while China has seen significant growth. The decline in Europe is attributed to various factors, including increased competition from Asia, the pandemic's impact, and new EU regulations. Spain has emerged as a leader in clinical trial starts within Europe, despite an overall decline in the region. Teljes cikk (Euronews.com)